Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03725293 · ClinicalTrials.gov registry record · NA
Midlines and Thrombophlebitis
A NA study, sponsored by Corewell Health East.
- Completed
- Registry status
- NA
- Development phase
- 212
- Enrollment target
NCT03725293 is a NA study that has completed, run by Corewell Health East. The registered enrollment target is 212 participants.
The verdict
NCT03725293, a NA study, has completed, sponsored by Corewell Health East.
- COMPLETED
- Registry status
- NA
- Development phase
- 212 participants
- Enrollment target
Study Summary
Peripherally inserted central catheters (PICCs) are central catheters that are placed via peripheral vein under ultrasound guidance and may be used for patients with difficult venous access for long-term central or peripheral infusion therapies as well as central venous pressure monitoring in a critical care setting. Although PICCs provide a great option for some patients, these catheters have known complications including catheter-related bloodstream infection, catheter-related venous thrombosis or clotting, malfunction, and high cost. Midline catheters represent a potentially attractive alternative to PICCs for peripheral infusions. As midlines have increased in popularity and new midlines have been introduced into the market, it is necessary to better understand complication profiles of various midline catheters, as it is likely that all catheters are not created equal. Specifically, the incidence of symptomatic catheter-related thrombosis is of interest. Some midline catheters are coated to provide protection against catheter-related venous thrombosis and/or catheter-related bloodstream infection. The theoretical benefit(s) of these catheters need further validation in human subjects.
Interventions
- DEVICE Angiodynamics BioFlo Midline Catheter
- DEVICE Teleflex Arrowg+ard Blue Advanced Midline Catheter
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 212 participants |
| Start Date | 2019-01-14 |
| Est. Completion | 2020-11-26 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03725293
The ClinicalTrials.gov registry entry for NCT03725293 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 212 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Corewell Health East, which has 106 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Angiodynamics BioFlo Midline Catheter is the first listed.
NCT03725293 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03725293 about?
NCT03725293 is a clinical study titled "Midlines and Thrombophlebitis". Peripherally inserted central catheters (PICCs) are central catheters that are placed via peripheral vein under ultrasound guidance and may be used for patients with difficult venous access for long-term central or peripheral infusion therapies as well as central venous pressure monitoring in a crit...
What is the current status of trial NCT03725293?
This trial is currently completed. It is a NA study. The enrollment target is 212 participants. The study started on 2019-01-14. Estimated completion is 2020-11-26.
What interventions are being tested in trial NCT03725293?
The interventions under investigation include: Angiodynamics BioFlo Midline Catheter (DEVICE), Teleflex Arrowg+ard Blue Advanced Midline Catheter (DEVICE).
Who is sponsoring clinical trial NCT03725293?
This trial is sponsored by Corewell Health East, which has 106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.